This update should put an end to the basher line about no revenues from the Saudi deal given the original projection put out in the PR when the deal was inked. But we all know it won't.

I wonder if the Singapore deal has similar issues with their FDA. If they do, we know its only a matter of time given past performance here and in the middle east.

So what can we expect? Nanologix is showing that they are taking market share in the US. I expect the middle east will begin taking market share followed by asia.

What about the share price? I expect whoever is trying to kill the Company will continue to try to do so until they realize that its a futile effort -- which would be when the Company no longer needs to raise capital by issuing shares.